Systemic inflammatory markers of persistent cerebral edema after aneurysmal subarachnoid hemorrhage

[1]  D. Perl,et al.  Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation , 2022, Cell.

[2]  M. Treggiari,et al.  A Double-Blind, Randomized, Placebo-Controlled Trial of Soluble Epoxide Hydrolase Inhibition in Patients with Aneurysmal Subarachnoid Hemorrhage , 2021, Neurocritical Care.

[3]  Jian Zhang,et al.  Effects of stellate ganglion block on early brain injury in patients with subarachnoid hemorrhage: a randomised control trial , 2021, BMC Anesthesiology.

[4]  S. Amaro,et al.  Edema Resolution and Clinical Assessment in Poor-Grade Subarachnoid Hemorrhage: Useful Indicators to Predict Delayed Cerebral Infarctions? , 2021, Journal of clinical medicine.

[5]  Ying-jian Liang,et al.  Persistently higher serum sCD40L levels are associated with outcome in septic patients , 2020, BMC Anesthesiology.

[6]  Ying Li,et al.  Role of eotaxin-1/CCL11 in sepsis-induced myocardial injury in elderly patients , 2020, Aging.

[7]  V. Seifert,et al.  Age dependency and modification of the Subarachnoid Hemorrhage Early Brain Edema Score. , 2020, Journal of neurosurgery.

[8]  John C. K. Kwok,et al.  Randomized, placebo-controlled, double-blind, pilot trial to investigate safety and efficacy of Cerebrolysin in patients with aneurysmal subarachnoid hemorrhage , 2019, BMC Neurology.

[9]  S. Blackburn,et al.  Inflammation in delayed ischemia and functional outcomes after subarachnoid hemorrhage , 2019, Journal of Neuroinflammation.

[10]  C. Reis,et al.  New risk score of the early period after spontaneous subarachnoid hemorrhage: For the prediction of delayed cerebral ischemia , 2019, CNS neuroscience & therapeutics.

[11]  E. Gizewski,et al.  Delayed Resolution of Cerebral Edema Is Associated With Poor Outcome After Nontraumatic Subarachnoid Hemorrhage , 2019, Stroke.

[12]  Mary F. McGuire,et al.  Disruption of thrombo‐inflammatory response and activation of a distinct cytokine cluster after subarachnoid hemorrhage , 2018, Cytokine.

[13]  A. Day,et al.  The Subarachnoid Hemorrhage Early Brain Edema Score Predicts Delayed Cerebral Ischemia and Clinical Outcomes , 2018, Neurosurgery.

[14]  G. Hergenroeder,et al.  Early Brain Injury Associated with Systemic Inflammation After Subarachnoid Hemorrhage , 2018, Neurocritical Care.

[15]  L. McCullough,et al.  CCL11 (Eotaxin-1) Levels Predict Long-Term Functional Outcomes in Patients Following Ischemic Stroke , 2017, Translational Stroke Research.

[16]  G. Hergenroeder,et al.  Systematic model of peripheral inflammation after subarachnoid hemorrhage , 2017, Neurology.

[17]  N. Rothwell,et al.  Reduction of inflammation after administration of interleukin-1 receptor antagonist following aneurysmal subarachnoid hemorrhage: results of the Subcutaneous Interleukin-1Ra in SAH (SCIL-SAH) study. , 2017, Journal of neurosurgery.

[18]  J. Lukens,et al.  Emerging Roles for the Immune System in Traumatic Brain Injury , 2016, Front. Immunol..

[19]  K. Osuka,et al.  Interleukin-6, MCP-1, IP-10, and MIG are sequentially expressed in cerebrospinal fluid after subarachnoid hemorrhage , 2016, Journal of Neuroinflammation.

[20]  G. E. Vates,et al.  Aneurysmal Subarachnoid Hemorrhage and Neuroinflammation: A Comprehensive Review , 2016, International journal of molecular sciences.

[21]  A. Ozpinar,et al.  The Role of Matrix Metalloproteinase-9 in Subarachnoid Hemorrhage-Induced White Matter Injury. , 2016, Neurosurgery.

[22]  A. Suzumura,et al.  CCL11 enhances excitotoxic neuronal death by producing reactive oxygen species in microglia , 2015, Glia.

[23]  L. Lorente.  New Prognostic Biomarkers in Patients With Traumatic Brain Injury , 2015, Archives of trauma research.

[24]  Y. Richard,et al.  The Signaling Role of CD40 Ligand in Platelet Biology and in Platelet Component Transfusion , 2014, International journal of molecular sciences.

[25]  G. Pradilla,et al.  Inflammation, Vasospasm, and Brain Injury after Subarachnoid Hemorrhage , 2014, BioMed research international.

[26]  W. Banks,et al.  Rapid Transport of CCL11 across the Blood-Brain Barrier: Regional Variation and Importance of Blood Cells , 2014, The Journal of Pharmacology and Experimental Therapeutics.

[27]  N. Rothwell,et al.  The effect of intravenous interleukin-1 receptor antagonist on inflammatory mediators in cerebrospinal fluid after subarachnoid haemorrhage: a phase II randomised controlled trial , 2014, Journal of Neuroinflammation.

[28]  G. Pierce,et al.  Localized Increase of Chemokines in the Lumen of Human Cerebral Aneurysms , 2013, Stroke.

[29]  Ji-Xin Shi,et al.  Intracisternal administration of SB203580, a p38 mitogen-activated protein kinase inhibitor, attenuates cerebral vasospasm via inhibition of tumor-necrosis factor-α , 2013, Journal of Clinical Neuroscience.

[30]  K. Kasischke,et al.  Excess Soluble CD40L Contributes to Blood Brain Barrier Permeability In Vivo: Implications for HIV-Associated Neurocognitive Disorders , 2012, PloS one.

[31]  N. Rothwell,et al.  Inflammation as a predictor for delayed cerebral ischemia after aneurysmal subarachnoid haemorrhage , 2012, Journal of NeuroInterventional Surgery.

[32]  K. Pattinson,et al.  Delayed cerebral ischaemia after subarachnoid haemorrhage: looking beyond vasospasm. , 2012, British journal of anaesthesia.

[33]  Paul Vespa,et al.  Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2012, Stroke.

[34]  W. Banks,et al.  Brain microvascular pericytes are immunoactive in culture: cytokine, chemokine, nitric oxide, and LRP-1 expression in response to lipopolysaccharide , 2011, Journal of Neuroinflammation.

[35]  J. Kaye,et al.  The aging systemic milieu negatively regulates neurogenesis and cognitive function , 2011, Nature.

[36]  R. Macdonald,et al.  Cerebral Infarction After Subarachnoid Hemorrhage Contributes to Poor Outcome by Vasospasm-Dependent and -Independent Effects , 2011, Stroke.

[37]  A. Algra,et al.  Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage , 2011, The Lancet Neurology.

[38]  J. Hillman,et al.  Differences in Cerebral Extracellular Response of Interleukin-1β, Interleukin-6, and Interleukin-10 After Subarachnoid Hemorrhage or Severe Head Trauma in Humans , 2011, Neurosurgery.

[39]  Joseph P Broderick,et al.  Definition of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage as an Outcome Event in Clinical Trials and Observational Studies: Proposal of a Multidisciplinary Research Group , 2010, Stroke.

[40]  H. Thorlacius,et al.  Soluble CD40L (CD154) is increased in patients with shock , 2010, Inflammation Research.

[41]  E. Wijdicks,et al.  Multidisciplinary management and emerging therapeutic strategies in aneurysmal subarachnoid haemorrhage , 2010, The Lancet Neurology.

[42]  R. Tamargo,et al.  Inflammation and cerebral vasospasm after subarachnoid hemorrhage. , 2010, Neurosurgery clinics of North America.

[43]  Hao Wang,et al.  Eotaxin Increases Monolayer Permeability of Human Coronary Artery Endothelial Cells , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[44]  John H. Zhang,et al.  Subarachnoid Hemorrhage: Is It Time for a New Direction? , 2009, Stroke.

[45]  E. Stroes,et al.  Microthrombosis after Aneurysmal Subarachnoid Hemorrhage: An Additional Explanation for Delayed Cerebral Ischemia , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[46]  Jan Hillman,et al.  Variations in the response of interleukins in neurosurgical intensive care patients monitored using intracerebral microdialysis. , 2007, Journal of neurosurgery.

[47]  John H. Zhang,et al.  Mechanisms of Early Brain Injury after Subarachnoid Hemorrhage , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[48]  R. Heyderman,et al.  Platelet and soluble CD40L in meningococcal sepsis , 2006, Intensive Care Medicine.

[49]  K. Stokes,et al.  CD40/CD40 Ligand Signaling in Mouse Cerebral Microvasculature After Focal Ischemia/Reperfusion , 2005, Circulation.

[50]  Marvin Bergsneider,et al.  Metabolic Crisis without Brain Ischemia is Common after Traumatic Brain Injury: A Combined Microdialysis and Positron Emission Tomography Study , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[51]  L. Niklason,et al.  Possible Role for Vascular Cell Proliferation in Cerebral Vasospasm After Subarachnoid Hemorrhage , 2003, Stroke.

[52]  A. Molyneux.  International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial , 2002, The Lancet.

[53]  S. Mayer,et al.  Global Cerebral Edema After Subarachnoid Hemorrhage: Frequency, Predictors, and Impact on Outcome , 2002, Stroke.

[54]  S. Mayer,et al.  Predictors of Cognitive Dysfunction After Subarachnoid Hemorrhage , 2002, Stroke.

[55]  Richard T. Lee,et al.  Overexpression of Eotaxin and the CCR3 Receptor in Human Atherosclerosis: Using Genomic Technology to Identify a Potential Novel Pathway of Vascular Inflammation , 2000, Circulation.

[56]  S. Juvela,et al.  Effects of nonsteroidal anti-inflammatory drugs on hemostasis in patients with aneurysmal subarachnoid hemorrhage. , 1999, Journal of neurosurgical anesthesiology.

[57]  G. Murray,et al.  Effect of fludrocortisone acetate in patients with subarachnoid hemorrhage. , 1989, Stroke.

[58]  W. Nyka,et al.  IL-1β, TNF-α, and IL-6 levels in gingival fluid and serum of patients with ischemic stroke. , 2016, Journal of oral science.

[59]  J. Kriz.  Inflammation in ischemic brain injury: timing is important. , 2006, Critical reviews in neurobiology.

[60]  A. Lagares,et al.  Grading of subarachnoid hemorrhage: modification of the World Federation of Neurosurgical Societies scale on the basis of data for a large series of patients. , 2005, Neurosurgery.

[61]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..